ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BIIB vs BNTX // DIVIDEND YIELD & FCF PAYOUT SAFETY

Biogen Inc. (NASDAQ) VS. BioNTech SE (NASDAQ) • 15-METRIC TALLY: BIIB 7 — BNTX 5
■ METRIC PARITY
dividend-safety
0.00%
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BIIB VS. BNTX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BIIB BNTX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 75.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 6.40% 9.90% -3.50 BNTX /roic <GO>
EV/EBITDA & P/E Valuation 22.3x 21.0x +1.30 BNTX /valuation <GO>
Free Cash Flow Yield 5.56% 2.21% +3.35 BIIB /fcf-yield <GO>
Operating Margin 15.90% 13.90% +2.00 BIIB /operating-margins <GO>
Net Profit Margin 13.10% 10.90% +2.20 BIIB /net-margins <GO>
Revenue Growth (YoY) 2.20% 14.30% -12.10 BNTX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.70 3.74 -0.04 BNTX /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 BNTX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.8 43.4 +18.40 BIIB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.10 1.02 +0.08 BIIB /macro-sensitivity <GO>
Forward P/E Multiple 26.5x 27.6x -1.10 BIIB /forward-pe <GO>
Enterprise Scale & Market Cap $36.90B $22.39B $14.51B BIIB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BIIB REV BNTX REV BIIB GROSS % BNTX GROSS % BIIB FCF BNTX FCF
FY 2025 $9.89B — 75.7% — $2.05B —
FY 2024 $9.68B — 76.1% — $2.72B —
FY 2023 $9.84B — — — $1.10B —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BIIB // BETA 1.10
BNTX // BETA 1.02